1 Min Read
March 7 (Reuters) - Erytech Pharma SA:
* To present preclinical results supporting immunotherapy potential of Erymmune platform at two upcoming medical meetings Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.